Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Phase 3
700
about 7.3 years
18+
183 sites in AL, AR, AZ +41
What this study is about
This trial is testing whether apixaban, a medication, is better than aspirin at preventing strokes or death in people who have had a brain bleed (ICH) and atrial fibrillation. The goal is to see if apixaban also improves how well patients can function after the stroke.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Apixaban
- 2.Take Aspirin
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
apixaban (Factor Xa inhibitor; prevents clot formation), acetylsalicylic acid
oral, oral (Delayed Release Oral Tablet)
Cardiology / Heart